Vitreous Hemorrhage

Phase 4 trials (8)

• ranibizumab
• propofol
• lidocaine
• proparacaine
• bevacizumab
• bupivacaine
• fentanyl
• midazolam

Phase 3 trials (3)

• hyaluronidase (ovine)
• aflibercept
• sodium chloride

Other trials (2)

• sevoflurane
• remifentanil

Organization Involved with Phase 4 Indications (5)

• Nihon University
• Rocky Vista University
• Hospital Regional Sao Jose
• KhonKaen University
• Hadi Clinic

Organization Involved with Phase 3 Indications (10)

• Regeneron
• ISTA Pharmaceuticals
• Bausch & Lomb
• Novartis
• National Institutes of Health (NIH)
• National Eye Institute (NEI)
• University of London
• Greater Houston Retina Research
• Jaeb Center for Health Research
• Charlotte Eye Ear Nose and Throat Assciates, PA

Organization Involved with Phase 2 Indications (5)

• St. Erik Eye Hospital
• University of Oklahoma
• Southeast Retina Center, Georgia
• Dean McGee Eye Institute
• University of Sao Paulo

Organization Involved with Other Experimental Indications (1)

• Seoul National University